Combinatorial therapy involving alpha5beta1 antagonists

• 收藏
• 分享

专利权人:

Inc.;Genentech

发明人:

Wu, Yan,Tessier-Lavigne, Marc,Ye, Weilan,Plowman, Greg,Chuntharapai, Anan

申请号：

AU2007319757

公开号：

AU2007319757B2

申请日:

2007.03.21

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

The present invention relates to the use of VEGF antagonists and alpha5beta1antagonists for treating cancer and inhibiting angiogenesis and/or vascularpermeability, including inhibiting abnormal angiogenesis in diseases. Thepresent invention also relates to use of a VEGFR agonists and alpha5beta1 agoniststo promote angiogenesis and vascular permeability. The present invention alsorelates to new anti-alpha5beta1 antibodies, compositions and kits comprisingthem and methods of making and using them.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/